Pluri (PLUR) Enterprise Value (2010 - 2025)
Pluri (PLUR) reported Enterprise Value of $481000.0 for Q4 2025, up 120.22% year-over-year from $218419.4 in Q4 2024, and up 105.15% quarter-over-quarter from -$9.3 million in Q3 2025.
Pluri (PLUR) Enterprise Value (2010 - 2025) Analysis & Trends
Pluri (PLUR) has 16 years of Enterprise Value data on file, last reported at $481000.0 in Q4 2025.
- Enterprise Value for Q4 2025 came in at $481000.0, up 120.22% year-over-year; the trailing twelve-month figure through Dec 2025 was $481000.0 (up 120.22% YoY), and the FY2025 annual result was -$14.6 million, up 40.66% from the prior year.
- Enterprise Value advanced to $481000.0 in Q4 2025 per PLUR's latest filing, from -$9.3 million in the prior quarter.
- Over five years, Enterprise Value peaked at $1.7 million in Q3 2024 and troughed at -$109.0 million in Q1 2021.
- A 5-year average of -$26.8 million and a median of -$17.2 million in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2024: Enterprise Value slumped 1149.55% in 2021, then soared 148.58% in 2024.
- A 5-year view of Enterprise Value shows it stood at -$19.7 million in 2021, then sank by 137.32% to -$46.8 million in 2022, then surged by 90.09% to -$4.6 million in 2023, then soared by 48.74% to -$2.4 million in 2024, then jumped by 120.22% to $481000.0 in 2025.
- Business Quant data shows PLUR's Enterprise Value at $481000.0 in Q4 2025, -$9.3 million in Q3 2025, and -$14.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -584.73 Mn |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | 481,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 481,000.00 |
| Sep 30, 2025 | -9.34 Mn |
| Jun 30, 2025 | -14.64 Mn |
| Mar 31, 2025 | -3.95 Mn |
| Dec 31, 2024 | -2.38 Mn |
| Sep 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | -24.67 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | -4.64 Mn |
| Sep 30, 2023 | -3.41 Mn |
| Jun 30, 2023 | -39.12 Mn |
| Mar 31, 2023 | -3.04 Mn |
| Dec 31, 2022 | -46.82 Mn |
| Sep 30, 2022 | -46.59 Mn |
| Jun 30, 2022 | -54.51 Mn |
| Mar 31, 2022 | -23.35 Mn |
| Dec 31, 2021 | -19.73 Mn |
| Sep 30, 2021 | -61.28 Mn |
| Jun 30, 2021 | -65.55 Mn |
| Mar 31, 2021 | -109.00 Mn |